Linaclotide utilization and potential for off-label use and misuse in three European countries.
Javier Cid-RuzafaBrian E LacyAnna SchultzeMai DuongYi LuMireia Raluy-CalladoRobert DonaldsonDarren WeissmanAinhoa Gómez-LumbrerasDan OuchiMaria Giner-SorianoRosa MorrosAhunna UkahDaniel PohlPublished in: Therapeutic advances in gastroenterology (2022)
Potential linaclotide off-label use and misuse appears limited, as evidenced by the small sizes of the patient subgroups at risk for off-label use and misuse.
Keyphrases